Related Experiment Video
Updated: Dec 28, 2025

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
NIPA2 regulates osteoblast function by modulating mitophagy in type 2 diabetes osteoporosis
Wei Zhao1, Weilin Zhang1, Hongdong Ma2
1Department of Orthopedics, the Fourth Hospital of China Medical University, Shenyang, Liaoning, China.
Abstract:
The highly selective magnesium transporter non-imprinted in Prader-Willi/Angelman syndrome region protein 2 (NIPA2) has recently been associated with the development and progression of type 2 diabetes osteoporosis, but the mechanisms involved are still poorly understood. Because mitophagy is involved in the pathology of type 2 diabetes osteoporosis, the present study aimed to explore the relationship among NIPA2, mitophagy and osteoblast osteogenic capacity. NIPA2 expression was reduced in C57BKS background db/db mice and in vitro models of type 2 diabetes osteoporosis, and the activation of mitophagy in primary culture osteoblast-derived from db/db mice and in high glucose-treated human fetal osteoblastic cells (hFOB1.19) was observed. Knockdown, overexpression of NIPA2 and pharmacological inhibition of peroxisome proliferator-activated receptor γ coactivator 1-α (PGC-1α) showed that NIPA2 increased osteoblast function, which was likely regulated by PTEN induced kinase 1 (PINK1)/E3 ubiquitin ligase PARK2 (Parkin)-mediated mitophagy via the PGC-1α/forkhead box O3a(FoxO3a)/mitochondrial membrane potential (MMP) pathway. Furthermore, the negative effect of mitophagy on osteoblast function was confirmed by pharmacological regulation of mitophagy and knockdown of Parkin. Taken together, these results suggest that NIPA2 positively regulates the osteogenic capacity of osteoblasts via the mitophagy pathway in type 2 diabetes.
Insights
Non-imprinted in Prader-Willi/Angelman syndrome region protein 2 (NIPA2) enhances osteoblast function by regulating mitophagy. This magnesium transporter is crucial for bone health in type 2 diabetes.
Area of Science:
- Endocrinology
- Molecular Biology
- Bone Biology
Background:
- The magnesium transporter NIPA2 is linked to type 2 diabetes and osteoporosis.
- Mechanisms connecting NIPA2, mitophagy, and osteoblast function in type 2 diabetes remain unclear.
Purpose of the Study:
- To investigate the relationship between NIPA2, mitophagy, and osteoblast osteogenic capacity in type 2 diabetes.
- To elucidate the molecular pathways involved in NIPA2-mediated regulation of osteoblast function.
Main Methods:
- Utilized db/db mice and high glucose-treated hFOB1.19 cells as in vitro models for type 2 diabetes.
- Performed NIPA2 knockdown and overexpression studies.
- Investigated the role of the PINK1/Parkin-mediated mitophagy pathway and PGC-1α/FoxO3a signaling.
Main Results:
- NIPA2 expression was reduced in type 2 diabetes models.
- NIPA2 overexpression enhanced osteoblast function, while knockdown impaired it.
- NIPA2-mediated mitophagy, involving PINK1/Parkin and PGC-1α/FoxO3a, positively regulated osteoblast function.
Conclusions:
- NIPA2 plays a positive regulatory role in osteoblast osteogenic capacity.
- The NIPA2-mitophagy pathway is a key mechanism influencing bone health in type 2 diabetes.
More Related Videos
08:40Visualization of Endogenous Mitophagy Complexes In Situ in Human Pancreatic Beta Cells Utilizing Proximity Ligation Assay
Published on: May 2, 2019
08:34Mechanism of Regulation of Adipocyte Numbers in Adult Organisms Through Differentiation and Apoptosis Homeostasis
Published on: June 3, 2016
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway
Cell Specific Gene Expression
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
The Intrinsic Apoptotic Pathway
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...